The CD47 (Lemzoparli) Biosimilar (HDBS0070) is a cutting-edge research tool designed for studying the CD47 protein, a key player in immune regulation and cancer biology. This biosimilar antibody is highly specific to human CD47 and has been rigorously validated for use in various research applications, including Western blot analysis.CD47, also known as the "don't eat me" signal, is a crucial molecule that helps cancer cells evade detection and destruction by the immune system. By targeting CD47, researchers can gain insights into tumor immune evasion mechanisms and develop potential immunotherapy strategies to improve cancer treatment outcomes.
This Anti-CD47 (Lemzoparli) Biosimilar (HDBS0070) is a valuable tool for scientists studying cancer immunology, tumor microenvironment, and therapeutic antibody development. Its high specificity and sensitivity make it an essential reagent for investigating the role of CD47 in cancer progression and developing novel targeted therapies.
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
TJ-011133, TJC-4
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG4
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
